From: Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district
Strategy
Antigens
BCG
PENTA
OPV
Measles
YFV
Fixed
37.7%
6.8%
15.7%
27.2%
Outreach
50.2%
7.1%
9.6%
38.8%
Global
43.0%
6.9%
13.5%
32.6%
National norm
< 50%
< 5%
< 25%